| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.31B | 10.94B | 11.23B | 8.49B | 7.48B | 7.15B |
| Gross Profit | 11.49B | 11.15B | 10.77B | 8.49B | 7.48B | 7.15B |
| EBITDA | 4.52B | 4.40B | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 3.55B | 3.42B | 3.40B | 2.82B | 2.61B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 390.67B | 373.05B | 346.92B | 355.87B | 340.35B | 320.74B |
| Cash, Cash Equivalents and Short-Term Investments | 36.04B | 46.83B | 34.75B | 51.43B | 40.66B | 24.59B |
| Total Debt | 26.41B | 27.96B | 26.14B | 18.91B | 20.09B | 18.92B |
| Total Liabilities | 364.44B | 348.74B | 322.66B | 335.06B | 20.09B | 18.92B |
| Stockholders Equity | 26.20B | 24.31B | 24.26B | 20.81B | 23.08B | 21.53B |
Cash Flow | ||||||
| Free Cash Flow | 6.23B | 8.47B | -21.55B | 10.85B | 13.11B | 25.37B |
| Operating Cash Flow | 7.62B | 9.85B | -20.19B | 11.77B | 14.04B | 26.37B |
| Investing Cash Flow | -4.31B | -86.00M | 1.98B | -4.96B | 822.00M | -7.25B |
| Financing Cash Flow | -2.23B | -1.69B | 5.02B | -3.38B | -448.00M | 451.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $71.36B | 11.74 | 11.31% | 3.63% | 1.94% | 30.93% | |
73 Outperform | $49.23B | 12.33 | 15.07% | 4.61% | -6.95% | 23.94% | |
73 Outperform | $73.65B | 10.95 | 11.71% | 4.22% | 2.95% | 33.77% | |
73 Outperform | $71.91B | 10.06 | 20.49% | 6.11% | 5.44% | 2.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $66.42B | 15.10 | 7.85% | 3.73% | 0.76% | -5.74% | |
65 Neutral | $79.84B | 13.59 | 8.69% | 1.48% | -2.22% | 24.37% |